News February 4, 2025 PHM’s Whitepaper Highlights Breakthroughs in Cancer Survival Private Health Management has been redefining cancer care for nearly two decades - ensuring our clients receive cutting-edge treatments, advanced diagnostics, and personalized guidance. The findings from our whitepaper, “Improving Cancer Survival: PHM’s Impact on Cancer Care” show that PHM clients with advanced cancer survived 2 to 4 times longer than patients in the gold-standard registries from the National Cancer Institute. Read More
Published Research February 4, 2025 Better Cancer Care. Better Outcomes. PHM has been redefining cancer care for nearly two decades – ensuring our clients receive cutting-edge treatments, advanced diagnostics, and personalized guidance. Our newly released whitepaper, “Improving Cancer Survival: PHM’s Impact on Cancer Care,” is grounded in 15 years of data. Our clients with advanced cancer survived 2 to 4 times longer than patients in the NCI. Read More
Ask Our Experts January 21, 2025 Advancing cervical cancer screening: What you need to know Cervical cancer is one of the most preventable cancers, yet it continues to claim the lives of thousands of women each year—many in the prime of their lives. With groundbreaking advancements in … Read More
Ask Our Experts January 21, 2025 Breaking ground in obesity care: new FDA approvals and innovations in weight management Obesity is a well-established risk factor for numerous chronic conditions, including type 2 diabetes, cardiovascular disease, liver disease, certain cancers, and obstructive sleep apnea. Evidence suggests that effective obesity treatment could potentially … Read More
Ask Our Experts January 21, 2025 What to know about combined, at-home COVID-19 and Flu testing This winter, navigating respiratory illnesses just got easier with the FDA’s authorization of the first at-home combination tests for SARS-CoV-2 and the flu. Healgen® Scientific’s Rapid Check COVID-19/Flu A&B Antigen Test simplifies … Read More
Ask Our Experts January 21, 2025 FDA approves nasal spray for emergency allergic reactions The U.S. Food and Drug Administration approved neffy®, the first-ever nasal spray form of epinephrine, offering a needle-free alternative for treating severe, life-threatening allergic reactions, or anaphylaxis. This innovation may encourage timely … Read More
